mesowatch-logo
Judge Dismisses Bid to Block J&J's $6.48B Talc Settlement
divider

Judge Dismisses Bid to Block J&J’s $6.48B Talc Settlement

Judge Dismisses Bid to Block J&J’s $6.48B Talc Settlement

Melissa Bill

Reading Time: 4 mins

Published On: July 1, 2024

Melissa Bill - author

Melissa Bill is a seasoned journalist from Florida with 17 years of experience. She holds a B.A. in Broadcast Journalism from Florida International University. Melissa's career began in Miami, where she worked in radio and TV news, and also wrote for The Miami Herald and The Sun. She currently reports on both local and national news, focusing on litigation, trials, and health topics. Melissa is committed to delivering insightful and reliable information to her readers.

More to Read

divider

June 28, 2024

Breaking Down the J&J Talc Settlement by State: Who Gets What?

>READ

divider

June 26, 2024

Study Confirms Ki67 Predicts Mesothelioma Treatment Success

>READ

divider

June 18, 2024

Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder

>READ

divider

June 13, 2024

Cancer Victims Motion Judge to Block J&J’s Bankruptcy Settlement

>READ

divider

June 12, 2024

ADAO Gains Support in Fight for Broader EPA Asbestos Ban

>READ

divider

June 11, 2024

J&J Agrees to Settle Consumer Deception Claims for $700 Million

>READ

divider

News & Data

divider

FILTER:

search
divider
WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns
WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns

Mary Pieper
3 mins read - July 8, 2024

The World Health Organization on Friday stated talc is “probably carcinogenic,” based on a study by the WHO’s International Agency for Research on Cancer (IARC).The study,...

Awareness

Promising Immunotherapy Case for Peritoneal Mesothelioma
Promising Immunotherapy Case for Peritoneal Mesothelioma

Mary Pieper
2 mins read - July 5, 2024

Frontiers in Oncology provisionally accepted a case report Friday suggesting the use of first-line nivolumab and ipilimumab could be more effective than chemotherapy in malignant...

Treatment

Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case
Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case

Mary Pieper
4 mins read - July 2, 2024

A scientist has scored a victory over Johnson & Johnson, which alleged her influential research linking asbestos-contaminated cosmetic products to the deadly cancer...

Settlements

Breaking Down the J&J Talc Settlement by State: Who Gets What?
Breaking Down the J&J Talc Settlement by State: Who Gets What?

John Edwards
6 mins read - June 28, 2024

The recent $700 million settlement by Johnson & Johnson marks a significant milestone in the battle over the safety of talc products. This settlement aims to resolve thousands...

Settlements

Study Confirms Ki67 Predicts Mesothelioma Treatment Success
Study Confirms Ki67 Predicts Mesothelioma Treatment Success

Mary Pieper
3 mins read - June 26, 2024

The results of an international study indicate that the expression of the nuclear protein Ki67 in the tumors of pleural mesothelioma patients can not only gauge the aggressiveness...

Research

Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder
Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder

Mary Pieper
3 mins read - June 18, 2024

Women who are at risk for ovarian or fallopian tube cancer due to prolonged use of Johnson & Johnson’s talc powder products could benefit from court-supervised health...

Settlements


June 13, 2024

Cancer Victims Motion Judge to Block J&J’s Bankruptcy Settlement

>READ

divider

June 12, 2024

ADAO Gains Support in Fight for Broader EPA Asbestos Ban

>READ

divider

June 11, 2024

J&J Agrees to Settle Consumer Deception Claims for $700 Million

>READ

divider

June 11, 2024

J&J Faces New Mesothelioma Trial in Texas Over Talc Claims

>READ

divider

June 5, 2024

J&J and Beasley Allen Clash Over $6.48 Billion Talc Settlement

>READ

divider

June 4, 2024

Historic $260M Verdict Against J&J in Asbestos-Tainted Talc Case

>READ

divider

June 3, 2024

Early RSO-021 Clinical Trial Provides Hope for Mesothelioma Patients

>READ

divider

June 2, 2024

Women File Class Action Suit Over J&J’s Attempts to Evade Talc Claims

>READ

divider

May 30, 2024

FDA Prioritizes Keytruda-Chemo Combo for Mesothelioma Patients

>READ

divider

Browse Categories

divider

Information provided by Mesowatch aims to provide legal and financial assistance and should not be considered a substitute for medical advice, treatment or diagnosis. Past performance and settlements do not guarantee or indicate the outcome of an individual case. Viewing this information or interacting with this website does not create an attorney-client relationship. DMCA.com Protection Status